Why are Biomarker Driven Trials Important in Cancer Treatment?
Cancer is a highly heterogeneous disease, meaning that tumors can vary greatly between patients. Traditional treatment methods, such as chemotherapy and radiation, often lack the specificity to target these unique tumor characteristics. Biomarker driven trials offer a more personalized approach, allowing treatments to be tailored to the individual patient's cancer. This can lead to better outcomes, including higher response rates and longer survival times.
